Fennec Pharmaceuticals Q3 EPS $0.12 Beats $0.10 Estimate, Sales $19.608M Beat $18.401M Estimate
Benzinga Newsdesk 3 hours ago
NewsEarningsEarnings Beats
Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.10 by 20 percent. This is a 700 percent increase over losses of $(0.02) per share from
Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.10 by 20 percent. This is a 700 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $19.608 million which beat the analyst consensus estimate of $18.401 million by 6.56 percent. This is a 57.34 percent increase over sales of $12.462 million the same period last year.